Correlation Between JPMorgan Chase and Tempest Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both JPMorgan Chase and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JPMorgan Chase and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between JPMorgan Chase Co and Tempest Therapeutics, you can compare the effects of market volatilities on JPMorgan Chase and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JPMorgan Chase with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of JPMorgan Chase and Tempest Therapeutics.

Diversification Opportunities for JPMorgan Chase and Tempest Therapeutics

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between JPMorgan and Tempest is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding JPMorgan Chase Co and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and JPMorgan Chase is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JPMorgan Chase Co are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of JPMorgan Chase i.e., JPMorgan Chase and Tempest Therapeutics go up and down completely randomly.

Pair Corralation between JPMorgan Chase and Tempest Therapeutics

Considering the 90-day investment horizon JPMorgan Chase is expected to generate 10.39 times less return on investment than Tempest Therapeutics. But when comparing it to its historical volatility, JPMorgan Chase Co is 32.88 times less risky than Tempest Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Tempest Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  152.00  in Tempest Therapeutics on August 28, 2024 and sell it today you would lose (60.00) from holding Tempest Therapeutics or give up 39.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

JPMorgan Chase Co  vs.  Tempest Therapeutics

 Performance 
       Timeline  
JPMorgan Chase 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in JPMorgan Chase Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, JPMorgan Chase displayed solid returns over the last few months and may actually be approaching a breakup point.
Tempest Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tempest Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

JPMorgan Chase and Tempest Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with JPMorgan Chase and Tempest Therapeutics

The main advantage of trading using opposite JPMorgan Chase and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JPMorgan Chase position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.
The idea behind JPMorgan Chase Co and Tempest Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
FinTech Suite
Use AI to screen and filter profitable investment opportunities